Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Government of Canada was posted on June 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Extended Warranty and Maintenance Services

Closed
International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract involves providing extended warranty and ongoing maintenance services for the UHPLC-DAD-FLD system to ensure its optimal performance and longevity. Services include preventive maintenance, timely repairs, and accessible technical support, aimed at minimizing downtime and addressing any operational issues promptly. This comprehensive support is essential for maintaining the reliability and efficiency of the equipment in a healthcare setting. Issued by the Department of Health under the Government of Canada, the subcontract falls within the NAICS code 811212, which covers machinery maintenance and repair services. The opportunity was posted on June 12, 2026, with a response deadline set for July 2, 2026. The place of performance is specified as Canada, reflecting a domestic service requirement. This contract is focused on ensuring critical healthcare infrastructure continues to function effectively through expert service and support.

General Info

Extended warranty and maintenance for UHPLC-DAD-FLD system; ensures optimal healthcare equipment performance.

Agency

Government of Canada → Department of HealthView Agency

NAICS

811212 - Computer and Office Machine Repair and MaintenanceView NAICS

Place of Performance

Canada, CAN

Set-Aside

NONE

Documents

This scope was carved out of 1000272585.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Ultra high-performance liquid chromatography system with diode array and fluorescence detection

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Department of Health
ContactsNo contacts available
OfficeN/A
Organization / Agency
Government of Canada → Department of Health
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Provide extended warranty and ongoing maintenance for the UHPLC-DAD-FLD system, including preventive maintenance, repairs, and technical support.

More opportunities from Government of Canada → Department of Health

Same awarding agency

NAICS: 541715
International
Request For Proposal (RFP) for Pharmacological testing of novel opioids, stimulants, and synthetic cannabinoids.
Solicitation # 1000273405
Health Canada is seeking proposals under solicitation 1000273405 to conduct in vitro pharmacological testing of novel psychoactive substances to support regulatory science and risk assessments regarding the illegal drug supply. The procurement is divided into three separate streams: Stream 1 focuses on emerging opioids at the Mu Opioid Receptor, Stream 2 addresses novel synthetic cannabinoids targeting CB1 and CB2 receptors, and Stream 3 evaluates stimulant compounds, specifically dopamine and VMAT2 uptake. Bidders may submit proposals for a single stream, two streams, or all three, with the possibility of up to three contracts being awarded. The selected contractors will be responsible for acquiring reference standards and control samples, obtaining necessary licenses for controlled substances, and performing rigorous laboratory experiments including assay validation and pharmacodynamic testing. Key deliverables include the measurement of metrics such as Ki, Emax, and EC50, followed by statistical analysis and the submission of draft and final reports. Timelines for completion vary by stream, with some activities extending up to 17.5 months from the date of the contract award. Technical and financial offers must be submitted separately for each stream by the deadline of September 18, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

11 days ago

DEADLINE

in 6 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS